Related Experiment Video
Updated: Jul 28, 2026

Identifying Protein-protein Interaction Sites Using Peptide Arrays
Published on: November 18, 2014
Role of protein-protein interactions in the antiapoptotic function of EWS-Fli-1
Ramugounder Ramakrishnan1, Yasuo Fujimura, Jian Ping Zou
1Drexel University, Broad and Vine, Philadelphia, PA 19102, USA.
Abstract:
In the majority of Ewing's family tumors, chromosomal translocation t(11;22) leads to aberrant fusion of RNA-binding protein EWS with DNA-binding ETS transcriptional factor Fli-1. EWS-Fli-1 has altered the transcriptional activity and modulating its downstream target genes through this transcriptional activity is thought to be responsible for this tumor. We have previously shown that both EWS-Fli-1 and Fli-1 have antiapoptotic activity against several apoptotic inducers. Here, we show that the transcriptional activity of EWS-Fli-1 and Fli-1 is not essential for its antiapoptotic activity. We also demonstrate that EWS-Fli-1 and Fli-1 interact with CBP through its amino-terminal region and inhibit the CBP-dependent transcriptional activity of RXR. This activity appears to be independent of DNA-binding activity of EWS-Fli-1. Introduction of the dominant-negative form of CBP into Ewing's sarcoma cells sensitizes these cells against genotoxic or retinoic-acid induced apoptosis. These results suggest that the ability of EWS-Fli-1/Fli-1 to target transcriptional cofactor(s) and modulate apoptotic pathways may be responsible for its antiapoptotic and tumorigenic activities.
Insights
Ewing
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Ewing's sarcoma is characterized by the EWS-Fli-1 fusion protein, a known driver of tumorigenesis.
- EWS-Fli-1 and Fli-1 possess antiapoptotic properties, contributing to tumor survival.
- The exact mechanisms underlying EWS-Fli-1's antiapoptotic and oncogenic functions are not fully elucidated.
Purpose of the Study:
- To investigate the role of transcriptional activity in the antiapoptotic function of EWS-Fli-1 and Fli-1.
- To identify the molecular interactions of EWS-Fli-1 and Fli-1 that mediate their antiapoptotic effects.
- To explore therapeutic strategies targeting EWS-Fli-1's interaction with cofactors.
Main Methods:
- Assessing the antiapoptotic activity of EWS-Fli-1 and Fli-1 independent of transcriptional activity.
- Co-immunoprecipitation assays to detect protein-protein interactions between EWS-Fli-1/Fli-1 and CBP.
- Functional assays involving dominant-negative CBP in Ewing's sarcoma cells to evaluate apoptosis induction.
Main Results:
- Transcriptional activity is not essential for the antiapoptotic function of EWS-Fli-1 and Fli-1.
- EWS-Fli-1 and Fli-1 interact with CBP via its N-terminal region, inhibiting RXR transcriptional activity.
- This inhibitory interaction is independent of EWS-Fli-1's DNA-binding capacity.
- Dominant-negative CBP sensitizes Ewing's sarcoma cells to apoptosis.
Conclusions:
- EWS-Fli-1/Fli-1's antiapoptotic and tumorigenic potential is mediated by targeting transcriptional cofactors, such as CBP.
- Modulating these cofactor interactions offers a potential therapeutic avenue for Ewing's sarcoma.
Related Concept Videos
Canonical Wnt Signaling Pathway
Regulation of the Unfolded Protein Response
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Regulation of Angiogenesis and Blood Supply
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

